Firm intentionHealthcare18 October 2026

TCGX Acquisition Corp. to acquire TriGemX Bio, Inc.

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
TCGX Acquisition Corp.
Target
TriGemX Bio, Inc.
Deal value
USD 361,000,000
Announced
18 October 2026
Status
Firm intention
Sector
Healthcare
Country
United States
Consideration
shares
What we know

TCGX Acquisition Corp. has agreed to acquire TriGemX Bio, Inc. in a strategic transaction valued at 361 million US dollars. The deal, announced on 18 October 2026, involves the exchange of shares as the sole form of consideration. TCGX Acquisition Corp. is incorporated in the Cayman Islands, while the target company, TriGemX Bio, operates in the United States. Both entities are situated within the healthcare sector. The transaction represents a significant consolidation of assets within this industry, with the equity value serving as the primary metric for the deal’s scale. No completion date has been reported to date, and the process remains in the firm intention stage. The structure indicates a straightforward acquisition where the buyer assumes control through share issuance. This move positions the combined entity to leverage existing resources within the healthcare landscape. The specific terms regarding post-closing integration or operational changes have not been detailed in the available data. The transaction is subject to regulatory approval.

Deal timeline

1 update
  1. Firm intention

    TCGX Acquisition Corp. firm intention to acquire TriGemX Bio, Inc.

    Item 1.01 Entry into a Material Definitive Agreement. On October 18, 2026, TCGX Acquisition Corp., a Cayman Islands exempted company (“ TCGX ”), TriGemX Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of TCGX (“ Merger Sub ”), and TriGemX Bio, Inc. (formerly known as Kallyope, Inc.), a Delaware corporation (“ TriGemX ”), entered into a Business Combination Agreement

    Source

For business owners

What would selling your own business involve?

Use the deal as a starting point, not a valuation benchmark. Learn the decisions behind a sale and apply them to your own preparation.

Guides are free to read. Free tools require email access; indicative results are not professional advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

Buyer history

TCGX Acquisition Corp.

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive